반응식
OC[C@@H](NC(C1C=NC(N2CCCC2)=C(OCCC)N=1)=O)CC(C)C.[CH:26]1([CH2:31][O:32][C:33]2[N:38]=[C:37]([C:39](O)=[O:40])[CH:36]=[N:35][C:34]=2[N:42]2[CH2:47][CH2:46][C:45]([F:49])([F:48])[CH2:44][CH2:43]2)[CH2:30][CH2:29][CH2:28][CH2:27]1.[CH3:50][O:51][C:52](=[O:59])[C@H:53]([CH2:55][CH:56]([CH3:58])[CH3:57])[NH2:54]>>[CH3:50][O:51][C:52](=[O:59])[C@@H:53]([NH:54][C:39]([C:37]1[CH:36]=[N:35][C:34]([N:42]2[CH2:47][CH2:46][C:45]([F:48])([F:49])[CH2:44][CH2:43]2)=[C:33]([O:32][CH2:31][CH:26]2[CH2:30][CH2:29][CH2:28][CH2:27]2)[N:38]=1)=[O:40])[CH2:55][CH:56]([CH3:58])[CH3:57]참가 물질
4
반응물 3
생성물 1
실험 절차
In analogy to the procedure described for the synthesis of 6-propoxy-5-pyrrolidin-1-yl-pyrazine-2-carboxylic acid ((S)-1-hydroxymethyl-3-methyl-butyl)-amide (example 10, step d) the title compounds was prepared from 6-cyclopentylmethoxy-5-(4,4-difluoro-piperidin-1-yl)-pyrazine-2-carboxylic acid and (S)-leucine methyl ester (commercially available). m/z (ES+): 469.1 (M+H).
출처 및 근거
- ORD 기록
- ord-e8626e9125ef487db2730203012e19f5
- 출처 데이터셋
- uspto-grants-2010_04
- 특허 번호
- US07691863B2
연결된 노트
불러오는 중…